We are live on ! Find out more
BAMCO Inc

BAMCO Inc Portfolio holdings

AUM $66.6B
1-Year Est. Return 7.35%
This Fund
S&P 500
This Quarter Est. Return
+24.59%
1 Year Est. Return
+7.35%
3 Year Est. Return
+62.2%
5 Year Est. Return
+84.27%
10 Year Est. Return
+776.55%
AUM
$32.6B
AUM Growth
+$4.92B
Cap. Flow
-$8.58M
Cap. Flow %
-0.03%
Top 10 Hldgs %
36.07%
Holding
374
New
31
Increased
133
Reduced
110
Closed
18

Top Buys

Rank Stock Value
1
GDRX icon
GoodRx Holdings
GDRX
+$82.5M
2
AMWL icon
American Well
AMWL
+$82.2M
3
SNOW icon
Snowflake
SNOW
+$71.3M
4
XLRN
Acceleron Pharma
XLRN
+$46.4M
5
RNG icon
RingCentral
RNG
+$41.5M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$270M
2
CSGP icon
CoStar Group
CSGP
+$78.1M
3
IDXX icon
Idexx Laboratories
IDXX
+$72.8M
4
TDOC icon
Teladoc Health
TDOC
+$64.6M
5
ANSS
Ansys
ANSS
+$38.5M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 25.59%
2 Technology 20.72%
3 Healthcare 15.48%
4 Financials 14.28%
5 Real Estate 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CG icon
101
Carlyle Group
CG
$17.5B
$67.8M 0.21%
2,749,675
-388,500
-12% -$10.5M
MELI icon
102
Mercado Libre
MELI
$99.7B
$67.3M 0.21%
62,186
-5,735
-8% -$6.22M
DKNG icon
103
DraftKings
DKNG
$12.5B
$66.5M 0.2%
1,130,900
-100,000
-8% -$3.89M
ATVI
104
DELISTED
Activision Blizzard
ATVI
$65.8M 0.2%
812,486
+3,925
+0.5% +$318K
MC icon
105
Moelis & Co
MC
$5.07B
$65.2M 0.2%
1,856,189
-22,025
-1% -$696K
NEOG icon
106
Neogen
NEOG
$2.54B
$64.2M 0.2%
1,641,240
+4,518
+0.3% +$173K
PRAH
107
DELISTED
PRA Health Sciences, Inc.
PRAH
$63.7M 0.2%
628,164
-26,200
-4% -$2.67M
XP icon
108
XP
XP
$8.96B
$62.9M 0.19%
1,507,981
+400,428
+36% +$18.3M
AXNX
109
DELISTED
Axonics, Inc. Common Stock
AXNX
$62.8M 0.19%
1,230,982
BN icon
110
Brookfield
BN
$92.3B
$61.8M 0.19%
3,491,510
-637,145
-15% -$11.4M
TXG icon
111
10x Genomics
TXG
$8.02B
$60.7M 0.19%
487,037
+63,332
+15% +$6.65M
EDU icon
112
New Oriental
EDU
$9.36B
$60.6M 0.19%
405,207
-24,164
-6% -$3.49M
TDG icon
113
TransDigm Group
TDG
$65.6B
$59.4M 0.18%
125,000
EPAM icon
114
EPAM Systems
EPAM
$5.92B
$59M 0.18%
182,652
+13,825
+8% +$4.13M
CPAY icon
115
Corpay
CPAY
$26.8B
$58.7M 0.18%
246,546
-90
-0% -$22.2K
CBRE icon
116
CBRE Group
CBRE
$43.7B
$56.4M 0.17%
1,200,046
-239,071
-17% -$10.9M
APH icon
117
Amphenol
APH
$194B
$56.3M 0.17%
2,079,744
-400
-0% -$10.5K
TWLO icon
118
Twilio
TWLO
$36.5B
$56.2M 0.17%
227,588
-36,458
-14% -$8.99M
CDW icon
119
CDW
CDW
$18.5B
$55.7M 0.17%
466,040
-87
-0% -$9.95K
HQY icon
120
HealthEquity
HQY
$7.97B
$54.1M 0.17%
1,053,436
-4,400
-0.4% -$242K
WEX icon
121
WEX
WEX
$6.72B
$52.1M 0.16%
375,000
CRWD icon
122
CrowdStrike
CRWD
$224B
$50.1M 0.15%
1,458,452
+14,712
+1% +$429K
AZEK
123
DELISTED
The AZEK Co
AZEK
$49.5M 0.15%
1,423,345
-63,010
-4% -$2.2M
PLNT icon
124
Planet Fitness
PLNT
$4.03B
$49.3M 0.15%
800,000
SDGR icon
125
Schrodinger
SDGR
$1.47B
$49.2M 0.15%
1,036,211
+85,197
+9% +$5.86M

Similar funds

BAMCO Inc's Q3 2020 Portfolio in Review

As of Q3 2020, BAMCO Inc held 374 positions worth $32.6B, up 18% from $27.7B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

BAMCO Inc's Q3 2020 filing shows 31 new, 133 increased, 110 reduced and 18 closed positions. Its largest new stake was GoodRx Holdings: 1,558,997 shares worth $86.7M. The largest sale was Tesla, an estimated $270M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

  • BAMCO Inc's largest Q3 2020 buy was GoodRx Holdings: 1,558,997 shares worth $86.7M.
  • BAMCO Inc added most to Acceleron Pharma in Q3 2020, an estimated $46.4M increase.
  • BAMCO Inc's biggest Q3 2020 reduction was Tesla, cutting an estimated $270M.
  • BAMCO Inc fully exited Performance Food Group in Q3 2020, selling an estimated $18.7M.
  • BAMCO Inc's ten largest holdings make up 36% of its $32.6B portfolio in Q3 2020.
  • BAMCO Inc opened 31 new positions and closed 18 in Q3 2020.
  • BAMCO Inc's portfolio value rose 18% quarter-over-quarter to $32.6B.

Based on BAMCO Inc's 13F filing for Q3 2020, filed 13 Nov 2020.